Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06855771
PHASE2

A Study of BMS-986504 in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)

Sponsor: Bristol-Myers Squibb

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the safety and efficacy of BMS-986504 monotherapy in participants with advanced or metastatic Non-small Cell Lung Cancer (NSCLC) with homozygous MTAP deletion after progression on prior therapies.

Official title: A Multicenter, Randomized, Open-label, Phase 2 Study Evaluating the Safety and Efficacy of BMS-986504 Monotherapy in Participants With Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion After Progression on Prior Therapies

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

130

Start Date

2025-09-09

Completion Date

2031-12-30

Last Updated

2026-03-24

Healthy Volunteers

No

Interventions

DRUG

BMS-986504

Specified dose on specified days

Locations (71)

Alaska Oncology and Hematology

Anchorage, Alaska, United States

Local Institution - 0099

Boise, Idaho, United States

Dana-Farber Cancer Institute

Boston, Massachusetts, United States

Karmanos Cancer Institute

Detroit, Michigan, United States

Washington University School of Medicine

St Louis, Missouri, United States

Memorial Sloan Kettering Cancer Center

New York, New York, United States

Local Institution - 0079

Shirley, New York, United States

Gabrail Cancer Center

Canton, Ohio, United States

Providence Portland Medical Center

Portland, Oregon, United States

Oregon Health and Science University

Portland, Oregon, United States

Fred Hutchison Cancer Center

Seattle, Washington, United States

Local Institution - 0084

Milwaukee, Wisconsin, United States

GenesisCare - Campbelltown

Campbelltown, New South Wales, Australia

Chris O'Brien Lifehouse

Camperdown, New South Wales, Australia

Princess Alexandra Hospital

Woolloongabba, Queensland, Australia

GenesisCare - St Andrew's

Adelaide, South Australia, Australia

Local Institution - 0039

Beijing, Beijing Municipality, China

The First Affiliated hospital of Xiamen University

Xiamen, Fujian, China

Guangxi Medical University Affiliated Tumor Hospital

Nanning, Guangxi, China

The First Affiliated Hospital of Nanchang University

Nanchang, Jiangxi, China

Local Institution - 0056

Changchun, Jilin, China

Shandong Cancer Hospital

Jinan, Shandong, China

Local Institution - 0044

Linyi, Shandong, China

Sir Run Run Shaw Hospital of Zhejiang University School of Medicine

Hangzhou, Zhejiang, China

Taizhou Hospital of Zhejiang Province

Linhai, Zhejiang, China

Local Institution - 0045

Marseille, Bouches-du-Rhône, France

Chu Grenoble Alpes

La Tronche, Isère, France

Hôpital Nord Guillaume-et-René-Laennec / CHU de Nantes

Saint-Herblain, Loire-Atlantique, France

Centre Hospitalier Régional Universitaire de Nancy - Hôpitaux de Brabois

Vandœuvre-lès-Nancy, Meurthe-et-Moselle, France

Hospices Civils de Lyon - Hopital Louis Pradel

Bron, Rhône, France

Hopitaux Universitaires Paris Centre-Hopital Cochin

Paris, France

Local Institution - 0107

Paris, France

Hôpital Tenon

Paris, France

Groupe hospitalier Paris saint Joseph

Paris, Île-de-France Region, France

Klinikum der Ludwig-Maximilians-Universitaet Muenchen

München, Bavaria, Germany

Universitätsklinikum Frankfurt Goethe-Universität

Frankfurt am Main, Hesse, Germany

Krankenhaus Martha-Maria Halle-Dölau

Halle, Saxony-Anhalt, Germany

Universitaetsklinikum Koeln

Cologne, Germany

Universitaetsklinikum Wuerzburg

Würzburg, Germany

AOU della Campania Luigi Vanvitelli

Naples, Campania, Italy

Istituto Nazionale Tumori IRCCS Fondazione Pascale

Naples, Campania, Italy

Fondazione IRCCS San Gerardo dei Tintori

Monza, Lombardy, Italy

ASST Grande Ospedale Metropolitano Niguarda

Milan, Milano, Italy

Istituto Oncologico Veneto IRCCS

Padova, Veneto, Italy

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola

Bologna, Italy

Fondazione IRCCS Istituto Nazionale dei Tumori

Milan, Italy

National Cancer Center Hospital East

Kashiwa, Chiba, Japan

Sendai Kousei Hospital

Sendai, Miyagi, Japan

Kansai Medical University Hospital

Hirakata, Osaka, Japan

Mazowiecki Szpital Onkologiczny

Wieliszew, Masovian Voivodeship, Poland

Szpital Specjalistyczny w Prabutach Spolka z o.o.

Prabuty, Poland

Institutul Oncologic Bucuresti "Prof. Dr. Alexandru Trestioreanu"

Bucharest, București, Romania

SC Radiotherapy Center Cluj SRL

Florești, Cluj, Romania

Centrul de Oncologie "Sfântul Nectarie"

Craiova, Dolj, Romania

Centrul de Diagnostic si Tratament Provita

Bucharest, Romania

Institutul Oncologic Cluj

Cluj-Napoca, Romania

S.C. Centrul de Oncologie Euroclinic S.R.L.

Iași, Romania

Institutul Regional de Oncologie

Iași, Romania

Hospital Universitari Vall d'Hebron

Barcelona, Barcelona [Barcelona], Spain

Institut Català d'Oncologia - L'Hospitalet

Hospitalet, Barcelona [Barcelona], Spain

Hospital Universitario Ramón y Cajal

Madrid, Madrid, Comunidad de, Spain

Hospital Universitario 12 de Octubre

Madrid, Madrid, Comunidad de, Spain

Hospital Universitario La Paz

Madrid, Madrid, Comunidad de, Spain

H.R.U Málaga - Hospital General

Málaga, Spain

Hospital Universitario Virgen Del Rocio

Seville, Spain

Hospital Universitari i Politecnic La Fe

Valencia, Spain

Karolinska Universitetssjukhuset Solna

Solna, Stockholms Län [se-01], Sweden

Sahlgrenska Universitetssjukhuset

Gothenburg, Västra Götalands Län [se-14], Sweden

Queen Elizabeth Hospital Birmingham

Birmingham, England, United Kingdom

Sarah Cannon Research Institute UK

London, London, City of, United Kingdom

Freeman Hospital

Newcastle upon Tyne, United Kingdom